🔗 Share this article

Given that the US proceeds with historic revisions to its vaccine guidelines, a particular individual has surfaced somewhat surprisingly: Høeg, a Danish American sports physician and epidemiologist who initially gained attention by expressing skepticism about Covid vaccinations during the global health crisis and has focused upon potential fatalities after Covid immunization in her brief position at the Food and Drug Administration.

Scheduled Changes to Childhood Vaccine Schedule

Health officials had intended to announce radical revisions to the childhood immunization program earlier this month, aligning the US with Denmark’s vaccine program, sources say – a substantial departure that would place the US out of alignment with many the global community with no evidence for public health gain. This reveal has been postponed until the next year.

Instead of Vinay Prasad, Tracy Beth Høeg is listed to present at the gathering. She was newly appointed temporary leader of the FDA’s drug evaluation center, the fifth person to run the office this calendar year.

A Shift at the Agency

This interim role may indicate a closer partnership between the drug and vaccine centers as Dr. Høeg and Prasad consolidate power at the FDA – and it suggests a increased emphasis upon dismantling long-standing vaccines at the FDA.

Dr. Høeg has frequently advocated for discontinuing certain childhood shot schedules in the US to become more like Denmark's approach, a society with nationalized medicine and a citizenry about the size of Wisconsin’s.

In her initial statements, she has continued to focus on immunizations – traditionally the purview of Prasad, head of the FDA’s CBER – instead of pharmaceutical oversight.

Questions Over Expertise

Dr. Høeg has little discernible track record in drug development, regulation or management, which has been standard for former leaders of the Center for Biologics Evaluation and Research. She has served at the FDA as a key advisor to the agency head and CBER since March.

“She appears not to have the necessary background” for overseeing the drug-regulation department, said a neurologist and psychiatrist. “She lacks experience running a clinical trial. She lacks experience in running a sizeable institution. She lacks background in industry regulation.”

Former heads of CBER would “grasp laws and regulations and the research of pharmaceutical innovation”, said Janet Woodcock. “Frankly, she lacks the type of experience that former directors who headed CBER have had.”

This division has an enormous workload at the FDA, the former commissioner emphasized.

“The public just focuses on the novel medication approvals, but the generic program clears numerous off-brand pharmaceuticals. There’s a biosimilars program, over-the-counter program and more, and every single one need to be looked after,” Woodcock noted. “The area you don’t keep your eye on, that is the part that I always told people is going to cause problems.”

Additionally, a substantial administrative element to the role, which oversees over 5,000 staff members. “It is a massive administrative position, if you do it right,” Woodcock added.

Response and Controversial Policies

When asked about questions about Dr. Høeg's credentials and whether this selection indicates greater collaboration among regulatory chiefs on immunizations, a spokesperson responded that the “questions rely on incorrect premises”.

“This background aligns with the duties of her role,” the official said, citing the months Høeg spent guiding the agency head on “drug safety and approval science, including predictive safety algorithms and immunization monitoring”.

As the temporary head, Høeg inherits the commissioner’s new fast-track approval initiative, a contentious expedited therapy clearance system that allegedly concerned her former heads. “By what process are these therapies being chosen for this expedited pathway? Who is making the decisions?” Howard asked. “There’s a lot of lack of transparency going on at the regulatory body right now.”

In general, he remarked, “the agency appears to be shifting towards more relaxed rules of most medications, aside from shots.”

Documented History on Immunizations

Regarding immunizations, Høeg has a more established, if concerning, track record, critics observe. She published a research paper using unverified crowd-sourced reports to determine the rate of heart inflammation after Covid immunization. She consulted for the Florida chief medical officer Joseph Ladapo, who allegedly have modified findings to imply Covid vaccines are more dangerous than they are.

Among her “policy goals” for the new government encompassed changing rules for recently developed shots and halting “non-essential” immunizations, she said following the vote on a online show. At the agency, Høeg has allegedly floated the idea of preventing adolescent males from receiving COVID-19 vaccines.

“She’s an all-around dogmatist who commences with her beliefs and works backwards to accommodate the data in a very misleading, fraudulent fashion,” Howard stated.

Gaining Influence and a “Revenge Tour”

Høeg joined other contrarians, {like|